Market Place
Sourcing Support
All News #Library
Biotech
Avalyn Seeks Public Debut To Support New Lung Drug Formulations
24 Apr 2026 //
BIOSPACE
Avalyn Plans IPO To Fund Ph. 3 Trials Of Inhaled Lung Drugs
09 Apr 2026 //
FIERCE BIOTECH
Pulmonary Fibrosis Biotech Avalyn Pharma Files For IPO
09 Apr 2026 //
ENDPOINTS
Avalyn Initiates AURA Ph2 Trial For Inhaled Nintedanib
23 Mar 2026 //
GLOBENEWSWIRE
Avalyn Presents At Pulmonary Fibrosis Foundation Summit 2025
21 Oct 2025 //
GLOBENEWSWIRE
Avalyn Pharma Appoints Jill Denning And Kimberley Cummings
01 Oct 2025 //
GLOBENEWSWIRE
Avalyn Pharma Secures $100M Series D for Pulmonary Fibrosis Drugs
22 Jul 2025 //
BIOSPACE
Avalyn Secures $100M for Advancement of Inhaled IPF Pills
22 Jul 2025 //
FIERCE BIOTECH
Avalyn Completes Oversubscribed $100 Million Series D Financing
22 Jul 2025 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.